2SEVENTY BIO INC's ticker is and the CUSIP is 901384107. A total of 142 filers reported holding 2SEVENTY BIO INC in Q3 2023. The put-call ratio across all filers is 3.19 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $5,449 | -63.1% | 1,389,953 | -4.6% | 0.05% | -56.7% |
Q2 2023 | $14,749 | +40.5% | 1,457,390 | +41.6% | 0.12% | +37.9% |
Q1 2023 | $10,496 | +23.5% | 1,029,040 | +13.4% | 0.09% | -29.3% |
Q4 2022 | $8,500 | -99.8% | 907,135 | +270.6% | 0.12% | +161.7% |
Q3 2022 | $3,561,000 | -0.0% | 244,745 | -9.3% | 0.05% | +6.8% |
Q2 2022 | $3,562,000 | -10.6% | 269,879 | +15.5% | 0.04% | -12.0% |
Q1 2022 | $3,985,000 | +20.6% | 233,585 | +81.2% | 0.05% | +47.1% |
Q4 2021 | $3,303,000 | – | 128,886 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kynam Capital Management, LP | 4,890,706 | $49,493,945 | 6.81% |
CHI Advisors LLC | 852,007 | $8,622,311 | 2.62% |
Casdin Capital, LLC | 2,023,913 | $20,482,000 | 1.79% |
Newtyn Management, LLC | 737,744 | $7,465,969 | 1.76% |
Bain Capital Life Sciences Investors, LLC | 1,408,901 | $14,258,078 | 1.47% |
DAFNA Capital Management LLC | 496,416 | $5,023,730 | 1.37% |
AlphaCentric Advisors LLC | 180,000 | $1,821,600 | 1.01% |
SECTORAL ASSET MANAGEMENT INC | 462,485 | $4,680,348 | 0.78% |
CLOUGH CAPITAL PARTNERS L P | 529,110 | $5,354,593 | 0.54% |
Bleichroeder LP | 255,230 | $2,582,928 | 0.52% |